| Q41684954 | 'E-boxes' as promoter elements in B cell lines and untransformed B lymphocytes |
| Q33290390 | 1-Aminocyclopropane-1-carboxylate synthase in tomato is encoded by a multigene family whose transcription is induced during fruit and floral senescence |
| Q34303119 | A CACGTG motif of the Antirrhinum majus chalcone synthase promoter is recognized by an evolutionarily conserved nuclear protein |
| Q28585539 | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo |
| Q24634609 | A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain |
| Q33575964 | A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor |
| Q24318898 | A human POU domain gene, mPOU, is expressed in developing brain and specific adult tissues |
| Q24317715 | A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor |
| Q38325341 | A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells |
| Q24315271 | A novel genetic system to isolate a dominant negative effector on DNA-binding activity of Oct-2 |
| Q33921920 | A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V kappa promoter |
| Q41305696 | A silencer and an adjacent positive element interact to modulate the activity of the human insulin promoter |
| Q35016297 | A simple method to renature DNA-binding proteins separated by SDS-polyacrylamide gel electrophoresis |
| Q38342131 | A single DNA-binding transcription factor is sufficient for activation from a distant enhancer and/or from a promoter position |
| Q40819029 | A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter |
| Q36773951 | Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters. |
| Q37062002 | Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by metallothionein |
| Q41236557 | An autoregulatory enhancer element of the Drosophila homeotic gene Deformed |
| Q36731893 | Analysis of Oct2-isoform expression in lipopolysaccharide-stimulated B lymphocytes. |
| Q41683573 | Analysis of abnormal expression of G-CSF gene in a novel tumor cell line (KHC 287) elaborating G-CSF, IL-1 and IL-6 with co-amplification of c-myc and c-ki-ras |
| Q40447774 | Anti-OTF-1 antibodies inhibit NFIII stimulation of in vitro adenovirus DNA replication |
| Q24533589 | Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers |
| Q24601319 | Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins |
| Q38339734 | Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements |
| Q38302908 | B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. |
| Q36604444 | B cell development and immunoglobulin transcription in Oct-1-deficient mice |
| Q59059941 | B-cell-specif ic coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation |
| Q40678198 | BLyF, a novel cell-type- and stage-specific regulator of the B-lymphocyte gene mb-1 |
| Q36726471 | Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor |
| Q28620968 | Both Oct-1 and Oct-2A contain domains which can activate the ubiquitously expressed U2 snRNA genes |
| Q24564107 | Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs |
| Q24291231 | CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression |
| Q71609649 | Cell differentiation in vitro and the expression of Oct-2 protein and oct-2 RNA |
| Q36382408 | Cell size regulation, a mechanism that controls cellular RNA accumulation: consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y and the liver-enriched transcription factor DBP. |
| Q41566088 | Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter |
| Q48941969 | Cell-specific expression of the human gonadotropin-releasing hormone gene in transgenic animals. |
| Q33866711 | Cell-specific transcriptional control of the mouse DNA-binding protein mC/EBP. |
| Q38142292 | Characterization of a DNA-binding protein system which is inversely correlated with class II expression |
| Q28646103 | Characterization of a negative retinoic acid response element in the murine Oct4 promoter |
| Q24559695 | Characterization of chicken octamer-binding proteins demonstrates that POU domain-containing homeobox transcription factors have been highly conserved during vertebrate evolution |
| Q40689345 | Chicken HDAC2 down-regulates IgM light chain gene promoter activity. |
| Q36959388 | Chicken beta B1-crystallin gene expression: presence of conserved functional polyomavirus enhancer-like and octamer binding-like promoter elements found in non-lens genes |
| Q33246568 | Chromosomal location of the octamer transcription factors, Otf-1, Otf-2, and Otf-3, defines multiple Otf-3-related sequences dispersed in the mouse genome |
| Q24294398 | Cloning and characterization of a human c-myc promoter-binding protein |
| Q42809816 | Cloning and characterization of the chick Oct binding factor OBF-1. |
| Q36826781 | Cloning and characterization of the murine B-cell specific transcriptional coactivator Bob1. |
| Q41521004 | Cloning and tissue-specific expression of the gene for mouse C-reactive protein |
| Q29620250 | Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells |
| Q24635381 | Cloning of cDNAs coding for human HMG I and HMG Y proteins: both are capable of binding to the octamer sequence motif |
| Q28508568 | Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers |
| Q24596982 | Cloning, chromosomal localization and expression pattern of the POU domain gene Oct-11 |
| Q32058411 | Comparison of sequence and function of the Oct-6 genes in zebrafish, chicken and mouse |
| Q41434010 | Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma × T cell hybrids |
| Q33590388 | Coordinate action of a proximal homeoprotein binding site and a distal sequence confers the Ultrabithorax expression pattern in the visceral mesoderm. |
| Q33411695 | DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic site containing DNAs |
| Q58450390 | DNA-binding domain ancestry |
| Q35804675 | Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated |
| Q35785980 | Demonstration of a divergent transcript from the bidirectional heavy chain immunoglobulin promoter VH441 in B-cells |
| Q41543354 | Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions |
| Q42818478 | Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells |
| Q40791425 | Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities |
| Q38304688 | Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: implications for B-cell specificity of the immunoglobulin heavy-chain enhancer |
| Q44258345 | Dissection of functional domains of the pituitary-specific transcription factor GHF-1. |
| Q40505363 | Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes |
| Q48239230 | Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming. |
| Q41347892 | Drosophila homoeotic genes encode transcriptional activators similar to mammalian OTF-2. |
| Q36719499 | Drosophila proliferating cell nuclear antigen (cyclin) gene: structure, expression during development, and specific binding of homeodomain proteins to its 5'-flanking region |
| Q41082106 | Enhancer activation by a single type of transcription factor shows cell type dependence |
| Q68355311 | Eukaryotic transcription factors |
| Q41690369 | Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling? |
| Q36464686 | Expression and Activity of the Transcription Factor SCIP during Glial Differentiation and Myelination |
| Q49058843 | Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity |
| Q28277007 | Expression of a large family of POU-domain regulatory genes in mammalian brain development |
| Q48078650 | Expression patterns of novel genes encoding homeodomain leucine-zipper proteins in Arabidopsis thaliana. |
| Q41204949 | Extinction of Ig genes expression in myeloma x fibroblast somatic cell hybrids is accompanied by repression of the oct-2 gene encoding a B-cell specific transcription factor |
| Q41577622 | Extinction of Oct-3/4 Gene Expression in Embryonal Carcinoma × Fibroblast Somatic Cell Hybrids is Accompanied by Changes in the Methylation Status, Chromatin Structure, and Transcriptional Activity of the Oct-3/4 Upstream Region |
| Q43182464 | Extinction of T cell receptor alpha-chain gene expression accompanied by loss of the lymphoid enhancer-binding factor 1 (LEF-1) in murine somatic cell hybrids |
| Q37837345 | From human autoantibodies to the fetal antibody repertoire to B cell malignancy: it's a small world after all. |
| Q40421477 | Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice |
| Q40522431 | Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms |
| Q28138243 | Functional interaction between Oct-1 and retinoid X receptor |
| Q38311057 | Functional interaction between different isoforms of the Oct-2 transcription factor expressed in neuronal cells |
| Q41595934 | Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1 |
| Q24678821 | Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression |
| Q28247692 | Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23–q25) and mouse chromosome 3 near Egf |
| Q39716358 | Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1 |
| Q40447891 | Genetic analysis of transcription factors implicated in B lymphocyte development. |
| Q36774107 | Helix-loo-helix proteins in the regulation of immunoglobulin gene transcription |
| Q33920748 | Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1 |
| Q33409717 | Heterogeneously initiated transcription from the pre-B- and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor-binding sites and initiation site sequences |
| Q24568349 | High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors |
| Q58989608 | Homoeo boxes, POU proteins and the limits to promiscuity |
| Q41606947 | Housekeeping Na,K-ATPase alpha 1 subunit gene promoter is composed of multiple cis elements to which common and cell type-specific factors bind |
| Q24561490 | Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene |
| Q24293962 | Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues |
| Q44430992 | I-POU: a POU-domain protein that inhibits neuron-specific gene activation |
| Q24561560 | Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box |
| Q39682683 | Identification and functional characterization of BTas transactivator as a DNA-binding protein |
| Q36708461 | Identification of a novel factor that interacts with an immunoglobulin heavy-chain promoter and stimulates transcription in conjunction with the lymphoid cell-specific factor OTF2. |
| Q36717517 | Identification of an octamer-binding site in the human kappa light-chain enhancer |
| Q36761913 | Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer |
| Q41098489 | Identification of factors regulating the expression of the human glucocerebrosidase gene |
| Q38343022 | Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene |
| Q45850803 | Immediate early protein of pseudorabies virus is a general transactivator but stimulates only suboptimally utilized promoters. A clue to specificity? |
| Q34306285 | Immunoglobulin enhancer and promoter motifs 5' of the B29 B-cell-specific gene |
| Q42601474 | In vitro binding to the leucine tRNA gene identifies a novel yeast homeobox gene |
| Q42479628 | Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner |
| Q40398799 | Inhibition of herpes simplex virus infection by ectopic expression of neuronal splice variants of the Oct-2 transcription factor |
| Q28587910 | Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer |
| Q29543470 | Interaction of Oct-1 with TFIIB |
| Q41082082 | Interference and synergism of glucocorticoid receptor and octamer factors. |
| Q38299790 | Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters |
| Q33291709 | Isolation and characterization of the gene encoding EF-1αO, an elongation factor 1-α expressed during early development of Xenopus laevis |
| Q24317240 | Isolation of the human genomic brain-2/N-Oct 3 gene (POUF3) and assignment to chromosome 6q16 |
| Q38337624 | Liver-specific gene expression: A-activator-binding site, a promoter module present in vitellogenin and acute-phase genes |
| Q40517596 | Lymphoid-specific transcriptional activation by components of the IgH enhancer: studies on the E2/E3 and octanucleotide elements |
| Q34320901 | Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box |
| Q38356590 | Mapping of the transcriptional repression domain of the lymphoid-specific transcription factor oct-2A. |
| Q35068608 | Mapping the transactivation domain of the Oct-6 POU transcription factor |
| Q53435594 | Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. |
| Q36687242 | Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells |
| Q33831064 | Molecular mechanisms of extinction: old findings and new ideas |
| Q40928375 | Molecular principles of Oct2-mediated gene activation in B cells |
| Q67871563 | Mouse chromosome 7 |
| Q35675706 | Mouse chromosome 7. |
| Q40530633 | Multiple Oct2 isoforms are generated by alternative splicing |
| Q48270366 | Multiple elements in the promoter of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells |
| Q24300369 | Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer |
| Q38342198 | Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors |
| Q38348953 | N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3 |
| Q42482263 | NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cells |
| Q28508721 | New type of POU domain in germ line-specific protein Oct-4 |
| Q48157917 | Novel DNA binding proteins participate in the regulation of human neurofilament H gene expression |
| Q34183708 | Novel mechanisms of class II major histocompatibility complex gene regulation |
| Q24313516 | OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins |
| Q36574089 | OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain |
| Q74261398 | Oct proteins are qualitative rather than quantitative regulators of kappa transcription |
| Q28620476 | Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes |
| Q25255861 | Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation |
| Q34041038 | Oct-2 facilitates functional preinitiation complex assembly and is continuously required at the promoter for multiple rounds of transcription |
| Q28506545 | Oct-4: a germline-specific transcription factor mapping to the mouse t-complex |
| Q24556538 | Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain |
| Q40655422 | Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity |
| Q38356251 | Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. |
| Q40819050 | Octamer binding proteins confer transcriptional activity in early mouse embryogenesis |
| Q33569207 | Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter |
| Q36722675 | Octamer-binding proteins in diverse hemopoietic cells. |
| Q38316492 | Overlapping positive and negative regulatory elements determine lens-specific activity of the delta 1-crystallin enhancer |
| Q40535937 | POU domain transcription factors from different subclasses stimulate adenovirus DNA replication |
| Q41082612 | POU proteins bend DNA via the POU-specific domain |
| Q67525041 | POU-specific domain of Oct-2 factor confers 'octamer' motif DNA binding specificity on heterologous Antennapedia homeodomain |
| Q39677670 | Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. |
| Q38314158 | Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability |
| Q24629845 | Positive and negative elements regulate a melanocyte-specific promoter |
| Q41644824 | Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene |
| Q72911892 | Production of recombinant antibodies in lymphoid and non-lymphoid cells |
| Q28620733 | Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter |
| Q35910996 | Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration |
| Q24604697 | Purification of early-B-cell factor and characterization of its DNA-binding specificity |
| Q41350631 | RNA polymerase II C-terminal domain required for enhancer-driven transcription |
| Q36665511 | Reconstitution of transcriptional activation domains by reiteration of short peptide segments reveals the modular organization of a glutamine-rich activation domain |
| Q36230644 | Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. |
| Q36317476 | Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy |
| Q38356344 | Regulation of human involucrin promoter activity by POU domain proteins |
| Q36572865 | Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. |
| Q28249579 | Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins |
| Q42129614 | Regulatory elements controlling pituitary-specific expression of the human prolactin gene |
| Q40447847 | Regulatory elements involved in the bidirectional activity of an immunoglobulin promoter |
| Q41736670 | Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages |
| Q41431521 | Repression of a herpes simplex virus immediate-early promoter by the Oct-2 transcription factor is dependent on an inhibitory region at the N terminus of the protein |
| Q39882501 | Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma |
| Q36811375 | Segments of the POU domain influence one another's DNA-binding specificity |
| Q28592898 | Short isoform of POU factor Brn-3b can form a heterodimer with Brn-3a that is inactive for octamer motif binding |
| Q36700925 | Simian virus 40 (SV40) T-antigen transcriptional activation mediated through the Oct/SPH region of the SV40 late promoter |
| Q40506234 | Stringent integrity requirements for both trans-activation and DNA-binding in a trans-activator, Oct3 |
| Q45948452 | Structural analyses of human developmentally regulated Vh3 genes. |
| Q34765130 | Structure-function analysis of the DNA binding domain ofSaccharomyces cerevisiaeABF1 |
| Q38340482 | Target Detection Assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein |
| Q40873369 | Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation |
| Q35851233 | The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation |
| Q28259912 | The B cell-specific coactivator OBF-1 (OCA-B, Bob-1) is inducible in T cells and its expression is dispensable for IL-2 gene induction |
| Q41670378 | The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity |
| Q41213754 | The DNA binding domain (POU domain) of transcription factor oct-1 suffices for stimulation of DNA replication |
| Q41543532 | The DNA binding specificity of the bipartite POU domain and its subdomains |
| Q40653846 | The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins |
| Q47356708 | The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. |
| Q36665493 | The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription |
| Q36562262 | The POU domain of SCIP/Tst-1/Oct-6 is sufficient for activation of an acetylcholine receptor promoter |
| Q24610899 | The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP |
| Q27930788 | The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes |
| Q52211686 | The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. |
| Q35889925 | The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions |
| Q42066326 | The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction |
| Q33919795 | The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription |
| Q77741483 | The different alternatively spliced isoforms of the Oct-2 transcription factor repress the involucrin promoter in a cell type-specific manner |
| Q44315513 | The domain model for eukaryotic DNA organization. 2: A molecular basis for constraints on development and evolution |
| Q37816327 | The early expression of some human autoantibody-associated heavy chain variable region genes is controlled by specific regulatory elements |
| Q36820980 | The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription |
| Q36732192 | The gene encoding the transcription factor SCIP has features of an expressed retroposon |
| Q35891939 | The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11 |
| Q36675781 | The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region |
| Q41387568 | The inhibitory domain in the Oct-2 transcription factor represses gene activity in a cell type-specific and promoter-independent manner |
| Q40421568 | The murine Hox-2.4 promoter contains a functional octamer motif |
| Q46881141 | The novel Solanum tuberosum calcium dependent protein kinase, StCDPK3, is expressed in actively growing organs |
| Q41082602 | The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer |
| Q40527591 | The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells |
| Q38333663 | The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons |
| Q33591163 | The octamer-binding proteins form multi-protein--DNA complexes with the HSV alpha TIF regulatory protein |
| Q36729328 | The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. |
| Q33743837 | The role of POU domain proteins in the regulation of mammalian pituitary and nervous system development. |
| Q24564741 | The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein |
| Q40453618 | The testis-specific octamer-binding protein of the sea urchin has a molecular weight of 85 kDa. |
| Q37149425 | The transcriptional coactivator Bob1 promotes the development of follicular T helper cells via Bcl6 |
| Q36720218 | The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes |
| Q36013163 | The weak, fine-tuned binding of ubiquitous transcription factors to the II-2 enhancer contributes to its T cell-restricted activity |
| Q41656802 | Three individual regulatory elements of the promoter positively activate the transcription of the murine gene encoding granulocyte colony-stimulating factor |
| Q24556539 | Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity |
| Q36500778 | Towards a molecular understanding of T-cell differentiation |
| Q35036645 | Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains |
| Q33919791 | Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells |
| Q41652229 | Transcription factor requirements for U2 snRNA-encoding gene activation in B lymphoid cells |
| Q34784369 | Transcription factors interacting with herpes simplex virus alpha gene promoters in sensory neurons |
| Q72550639 | Transcription factors: an overview |
| Q41748770 | Transcription of the promoter of the rat NF-1 gene depends on the integrity of an Sp1 recognition site. |
| Q38289155 | Transcriptional activation and repression, two properties of the lymphoid-specific transcription factor Oct-2a |
| Q46076067 | Transcriptional controls underlying Schwann cell differentiation and myelination |
| Q35850917 | Transcriptional regulatory elements of the RAS2 gene of Saccharomyces cerevisiae |
| Q37639988 | Transformation by homeobox genes can be mediated by selective transcriptional repression. |
| Q41854472 | Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site |
| Q28575317 | Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule P0 |
| Q36678035 | Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism |
| Q72080558 | Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3 |
| Q34209930 | Two diverged human homeobox genes involved in the differentiation of human hematopoietic progenitors map to chromosome 1, bands q41-42.1 |
| Q24293444 | Two members of an HNF1 homeoprotein family are expressed in human liver |
| Q42633662 | Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription |
| Q40531520 | Xenopus laevis Oct-1 does not bind to certain histone H2B gene promoter octamer motifs for which a novel octamer-binding factor has high affinity |
| Q36363138 | YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes |
| Q40404963 | Zebrafish pou[c]: a divergent POU family gene ubiquitously expressed during embryogenesis |
| Q24596854 | cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif |
| Q33198212 | dOct2, a Drosophila Oct transcription factor that functions in yeast |
| Q68331422 | vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression |